Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-045617
Filing Date
2025-03-26
Accepted
2025-03-26 20:25:29
Documents
2
Period of Report
2025-03-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3664
2 EX-24 ck0001697532-ex24.htm EX-24 14962
  Complete submission text file 0000950170-25-045617.txt   20155
Mailing Address C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY BOULDER CO 80301
Business Address
Hooks Corwin Dale (Reporting) CIK: 0001665347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38898 | Film No.: 25774860

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Issuer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)